Marcom Globe Italy
SEE OTHER BRANDS

Informing on media and advertising news in Italy

Russia requires all migrant workers to test for hepatitis

(MENAFN) Starting in March 2026, all labor migrants entering Russia will be required to undergo testing for viral hepatitis B and C, expanding the country’s existing medical screening regulations. The new rules will cover foreign citizens and stateless individuals arriving for work, as well as those applying for refugee status or temporary asylum.

Medical examinations are mandatory for migrants. Without completing them, individuals cannot obtain work permits, temporary residency, or permanent residency in Russia. Labor migrants must complete their medical tests within 30 calendar days of arrival, while non-working arrivals have up to 90 days. Current screenings already include checks for drugs and infectious diseases such as HIV, tuberculosis, syphilis, and leprosy.

The updated health screening measures were proposed earlier this year by a migration policy working group led by State Duma Deputy Speaker Irina Yarovaya. She said the changes aim to strengthen health monitoring of foreign arrivals and prevent the spread of dangerous infections.

Labor migrants are a vital component of Russia’s economy, filling key roles in construction, agriculture, and service sectors. Most come from Central Asia, drawn by higher wages than in their home countries. The influx has, however, prompted discussions about public health and social stability, leading Russian authorities to introduce stricter health requirements alongside enforcement measures.

In addition to the expanded screenings, Russia has intensified efforts to combat illegal immigration. Earlier this year, President Vladimir Putin signed a decree establishing a new state agency within the Interior Ministry to oversee migration management. The Kremlin said the move is intended to ensure compliance with Russian laws among migrants, reduce illegal activity, and bring order to the country’s migration processes.

MENAFN16102025000045017640ID1110204221


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions